Co-Management and Co-Monitoring of Patients Receiving CAR T-Cell Treatment: Transitions Between the Academic and Community Centers

Opinion
Video

Panelists discuss how, a collaborative approach to co-managing and co-monitoring patients receiving CAR-TCAR T-cell therapy patients, ensuring continuity of care as they transition to community settings. We They employ detailed care plans, electronic health records integration, and regular follow-ups with community providers to facilitate seamless transitions.

Video content above is prompted by the following:

  • Describe your institution’'s approach to the co-management and co-monitoring of patients receiving CAR-TCAR T-cell therapy, particularly in the transition back to the community setting.
  • Can you share any specific strategies or tools your institution utilizes to facilitate seamless transitions of care between the academic center and community practices for patients receiving CAR-TCAR T-cell therapy patients?
Recent Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
6 experts are featured in this series.
6 experts are featured in this series.
Related Content